IRVINE, Calif., and LITTLE FALLS, N.J., June 13 /PRNewswire/ -- Relsys International, the leading provider of software solutions for adverse event reporting, pharmacovigilance and risk management, announced today that it has extended its partnership with Sentrx, a leading provider of technology-enabled services for global drug safety, to host Relsys’ Argus Safety(TM) solution. The hosted model provides an opportunity for smaller organizations to meet their drug safety commitments. Nearly twenty pharmaceutical and biotechnology companies are already realizing the benefits of this partnership.
